Ellevest, Inc. Atara Biotherapeutics, Inc. Transaction History

Ellevest, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$2.85 - $5.18 $51 - $93	18 New	18 $0
Q2 2022 Jul 18, 2022	SELL	$4.69 - $9.84 $628 - $1,318	-134 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$11.99 - $17.9 $203 - $304	17 Added 14.53%	134 $2,000
Q1 2021 May 03, 2021	SELL	$14.0 - $20.72 $266 - $393	-19 Reduced 13.97%	117 $2,000
Q4 2020 Feb 04, 2021	BUY	$12.67 - $26.23 $240 - $498	19 Added 16.24%	136 $3,000

Q3 2020 Oct 26, 2020	BUY	$11.92 - $15.87 $536 - $714	45 Added 62.5%	117 $2,000
Q2 2020 Jul 06, 2020	SELL	$7.53 - $14.93 $120 - $238	-16 Reduced 18.18%	72 $1,000
Q1 2020 Apr 13, 2020	BUY	$5.69 - $17.78 $273 - $853	48 Added 120.0%	88 $1,000
Q4 2019 Feb 05, 2020	BUY	$10.89 - $16.79 $435 - $671	40 New	40 $1,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $781M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.